Hecheng Li

Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment

Yingxia Zheng, Zheyi Chen, Yichao Han et al. · Nature Communications · 2020 · 469 citations · Full text

Life Sciences, Immunology, Oncology +17

Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)

Chengqiang Li, Shengguang Zhao, Yuyan Zheng et al. · European Journal of Cancer · 2020 · 322 citations

Medicine, Oncology, Pharmacology +13

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 196 citations · Full text

Medicine, Oncology, Pharmacology +14

Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma

Yang Yang, Bin Li, Jun Yi et al. · Annals of Surgery · 2021 · 194 citations

Medicine, Surgery, General Surgery +15

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Hao Wang, Han Tang, Yong Fang et al. · JAMA Surgery · 2021 · 185 citations · Full text

Medicine, Oncology, Surgery +15